Your browser doesn't support javascript.
loading
MYC-driven U2SURP regulates alternative splicing of SAT1 to promote triple-negative breast cancer progression.
Deng, Ling; Liao, Li; Zhang, Yin-Ling; Hu, Shu-Yuan; Yang, Shao-Ying; Ma, Xiao-Yan; Huang, Min-Ying; Zhang, Fang-Lin; Li, Da-Qiang.
Affiliation
  • Deng L; Shanghai Cancer Center and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Liao L; Shanghai Cancer Center and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, 200032, China; Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 2000
  • Zhang YL; Shanghai Cancer Center and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, 200032, China; Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 2000
  • Hu SY; Shanghai Cancer Center and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Yang SY; Shanghai Cancer Center and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Ma XY; Department of Breast Surgery, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Huang MY; Shanghai Cancer Center and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Zhang FL; Shanghai Cancer Center and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, 200032, China; Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 2000
  • Li DQ; Shanghai Cancer Center and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, 200032, China; Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 2000
Cancer Lett ; 560: 216124, 2023 04 28.
Article in En | MEDLINE | ID: mdl-36907504
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ribonucleoproteins / Acetyltransferases / Proto-Oncogene Proteins c-myc / Alternative Splicing / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Lett Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ribonucleoproteins / Acetyltransferases / Proto-Oncogene Proteins c-myc / Alternative Splicing / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Lett Year: 2023 Document type: Article Affiliation country: Country of publication: